The Hydration Pharmaceuticals Co Ltd

ASX:HPC (Australia)  
A$ 0.01 (0%) May 24
At Loss
Market Cap:
A$ 3.96M ($ 2.63M)
Enterprise V:
A$ 7.07M ($ 4.69M)
Volume:
409.84K
Avg Vol (2M):
153.02K
Volume:
409.84K
At Loss

Business Description

Description
The Hydration Pharmaceuticals Co Ltd is engaged in the marketing and sale of liquid, tablet and powder hydration solution products into the North American markets of Canada and the United States. Some of its products include Hydration + Immune System Boost, Effervescent Electrolyte Tablets, Oral Rehydration Solution, and Immunity Booster Bundle.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.47
Equity-to-Asset -0.05
Debt-to-Equity -10.87
Debt-to-EBITDA -0.52
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.33
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 26.24
9-Day RSI 38.11
14-Day RSI 40.98
6-1 Month Momentum % -60
12-1 Month Momentum % -80.96

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.13
Quick Ratio 1.37
Cash Ratio 0.59
Days Inventory 200.74
Days Sales Outstanding 51.8
Days Payable 94.01

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 28.61

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 53.71
Operating Margin % -77.11
Net Margin % -80.7
FCF Margin % -57.06
ROE % -626.58
ROA % -110.94
ROIC % -341.12
ROC (Joel Greenblatt) % -351.56
ROCE % -160.3

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.17
EV-to-EBIT -0.63
EV-to-EBITDA -0.63
EV-to-Revenue 0.47
EV-to-FCF -0.82
Earnings Yield (Greenblatt) % -157.88
FCF Yield % -215.74

Financials

ASX:HPC's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

The Hydration Pharmaceuticals Co Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 14.987
EPS (TTM) (A$) -0.06
Beta 0
Volatility % 53.62
14-Day RSI 40.98
14-Day ATR (A$) 0.000259
20-Day SMA (A$) 0.0135
12-1 Month Momentum % -80.96
52-Week Range (A$) 0.012 - 0.060103
Shares Outstanding (Mil) 304.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

The Hydration Pharmaceuticals Co Ltd Filings

Filing Date Document Date Form
No Filing Data

The Hydration Pharmaceuticals Co Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

The Hydration Pharmaceuticals Co Ltd Frequently Asked Questions

What is The Hydration Pharmaceuticals Co Ltd(ASX:HPC)'s stock price today?
The current price of ASX:HPC is A$0.01. The 52 week high of ASX:HPC is A$0.06 and 52 week low is A$0.01.
When is next earnings date of The Hydration Pharmaceuticals Co Ltd(ASX:HPC)?
The next earnings date of The Hydration Pharmaceuticals Co Ltd(ASX:HPC) is .
Does The Hydration Pharmaceuticals Co Ltd(ASX:HPC) pay dividends? If so, how much?
The Hydration Pharmaceuticals Co Ltd(ASX:HPC) does not pay dividend.

Press Release

Subject Date
No Press Release